| 4 | A serum-induced gene signature in hepatocytes is associated with pediatric nonalcoholic fatty liver disease. (Hang Nghiem-Rao T, Johnson JS, Pan A, Atkinson SN, Behling C, Simpson PM, Holtz ML, Weinstock GM, Schwimmer JB, Salzman NH) J Pediatr Gastroenterol Nutr 2024 Apr;78(4):886-897 1 Citation |
| 1 | CD47-SIRPĪ± axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis. (Shi H, Wang X, Li F, Gerlach BD, Yurdagul A Jr, Moore MP, Zeldin S, Zhang H, Cai B, Zheng Z, Valenti L, Tabas I) Sci Transl Med 2022 Nov 23;14(672):eabp8309 58 Citations |
| 1 | The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children. (Chaidez A, Pan Z, Sundaram SS, Boster J, Lovell M, Sokol RJ, Mack CL) Hepatol Commun 2022 Nov;6(11):3015-3023 27 Citations |
| 1 | Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis. (Sourianarayanane A, McCullough AJ) Clin Res Hepatol Gastroenterol 2022;46(7):101997 20 Citations |
| 1 | Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. (Ochoa-Rios S, O'Connor IP, Kent LN, Clouse JM, Hadjiyannis Y, Koivisto C, Pecot T, Angel PM, Drake RR, Leone G, Mehta AS, Rockey DC) Mol Cell Proteomics 2022 May;21(5):100225 15 Citations |
| 1 | Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring. (Fu Q, North PE, Ke X, Huang YW, Fritz KA, Majnik AV, Lane RH) J Nutr 2021 Oct 01;151(10):3102-3112 5 Citations |
| 1 | Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease. (Khayat A, Vitola B) J Pediatr 2021 Dec;239:155-160 14 Citations |
| 1 | The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. (Motamed N, Nikkhah M, Karbalaie Niya MH, Khoonsari M, Perumal D, Ashrafi GH, Faraji AH, Maadi M, Ajdarkosh H, Safarnezhad Tameshkel F, Moradi-Lakeh M, Miri SM, Arsang-Jang S, Zamani F) Clin Res Hepatol Gastroenterol 2021 Nov;45(6):101567 13 Citations |
| 1 | A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis. (Bashyam A, Frangieh CJ, Raigani S, Sogo J, Bronson RT, Uygun K, Yeh H, Ausiello DA, Cima MJ) Nat Biomed Eng 2021 Mar;5(3):240-251 21 Citations |
| 1 | Hepatic Artery Thrombosis and Takotsubo Syndrome After Liver Transplantation - Which Came First? (Luu LA, Rawashdeh B, Goldaracena N, Agarwal A, McCracken EK, Sahli ZT, Oberholzer J, Pelletier SJ) Am J Case Rep 2020 Apr 14;21:e920263 6 Citations |
| 1 | Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis. (Wang X, Cai B, Yang X, Sonubi OO, Zheng Z, Ramakrishnan R, Shi H, Valenti L, Pajvani UB, Sandhu J, Infante RE, Radhakrishnan A, Covey DF, Guan KL, Buck J, Levin LR, Tontonoz P, Schwabe RF, Tabas I) Cell Metab 2020 May 05;31(5):969-986.e7 154 Citations |
| 1 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLARĀ trials. (Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Kohli A, Sarin S, Caldwell SH, Alkhouri N, Shiffman ML, Camargo M, Li G, Kersey K, Jia C, Zhu Y, Djedjos CS, Subramanian GM, Myers RP, Gunn N, Sheikh A, Anstee QM, Romero-Gomez M, Trauner M, Goodman Z, Lawitz EJ, Younossi Z, STELLAR-3, STELLAR-4 Investigators) J Hepatol 2020 Jul;73(1):26-39 400 Citations |
| 1 | Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. (Cai B, Dongiovanni P, Corey KE, Wang X, Shmarakov IO, Zheng Z, Kasikara C, Davra V, Meroni M, Chung RT, Rothlin CV, Schwabe RF, Blaner WS, Birge RB, Valenti L, Tabas I) Cell Metab 2020 Feb 04;31(2):406-421.e7 203 Citations |
| 1 | Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. (Schwimmer JB, Johnson JS, Angeles JE, Behling C, Belt PH, Borecki I, Bross C, Durelle J, Goyal NP, Hamilton G, Holtz ML, Lavine JE, Mitreva M, Newton KP, Pan A, Simpson PM, Sirlin CB, Sodergren E, Tyagi R, Yates KP, Weinstock GM, Salzman NH) Gastroenterology 2019 Oct;157(4):1109-1122 232 Citations |
| 1 | [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease]. (Ren SM, Mei L, Huang H, Cao SF, Zhao RH, Zheng PY) Zhonghua Gan Zang Bing Za Zhi 2019 May 20;27(5):369-375 |
| 1 | Considering Bariatric Surgery in Patients With Nonalcoholic Steatohepatitis-Worth the Risk. (Waits SA, Sheetz KH, Ghaferi AA) JAMA Netw Open 2019 Feb 01;2(2):e190053 4 Citations |
| 1 | Zinc oxide nanoparticles attenuate hepatic steatosis development in high-fat-diet fed mice through activated AMPK signaling axis. (Dogra S, Kar AK, Girdhar K, Daniel PV, Chatterjee S, Choubey A, Ghosh S, Patnaik S, Ghosh D, Mondal P) Nanomedicine 2019 Apr;17:210-222 43 Citations |
| 1 | HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease. (Chandrashekaran V, Seth RK, Dattaroy D, Alhasson F, Ziolenka J, Carson J, Berger FG, Kalyanaraman B, Diehl AM, Chatterjee S) Redox Biol 2017 Oct;13:8-19 63 Citations |
| 1 | Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. (Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA) HPB (Oxford) 2017 Aug;19(8):706-712 4 Citations |
| 1 | Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation. (Sourianarayanane A, Arikapudi S, McCullough AJ, Humar A) Eur J Gastroenterol Hepatol 2017 Apr;29(4):481-487 38 Citations |
| 1 | Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. (Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, Charlton M) Gastroenterology 2017 Apr;152(5):1090-1099.e1 470 Citations |
| 1 | Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis. (Sourianarayanane A, Talluri J, Humar A, McCullough AJ) Eur J Gastroenterol Hepatol 2017 May;29(5):516-523 29 Citations |
| 2 | Serotonin Syndrome Resulting From Acute Decompensation of Nonalcoholic Steatohepatitis Cirrhosis in a Patient Chronically Treated With Citalopram and Tramadol. (Gollapudy S, Cronin DC, Pagel PS, Boettcher BT) J Cardiothorac Vasc Anesth 2017 Aug;31(4):1385-1388 3 Citations |
| 1 | Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. (Cepero-Donates Y, Lacraz G, Ghobadi F, Rakotoarivelo V, Orkhis S, Mayhue M, Chen YG, Rola-Pleszczynski M, Menendez A, Ilangumaran S, Ramanathan S) Cytokine 2016 Jun;82:102-11 59 Citations |
| 1 | The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. (Goh GB, Issa D, Lopez R, Dasarathy S, Dasarathy J, Sargent R, Hawkins C, Pai RK, Yerian L, Khiyami A, Pagadala MR, Sourianarayanane A, Alkhouri N, McCullough AJ) J Gastroenterol Hepatol 2016 May;31(5):995-1000 22 Citations |
| 1 | Reply: To PMID 25479138. (Shteyer E, Smith B) Gastroenterology 2015 Jul;149(1):261-2 |
| 1 | NADPH Oxidase-Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment. (Das S, Alhasson F, Dattaroy D, Pourhoseini S, Seth RK, Nagarkatti M, Nagarkatti PS, Michelotti GA, Diehl AM, Kalyanaraman B, Chatterjee S) Am J Pathol 2015 Jul;185(7):1944-57 50 Citations |
| 1 | Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease. (Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Pai RK, Yerian L, Khiyami A, Sourianarayanane A, Sargent R, Hawkins C, Dasarathy S, McCullough AJ) Dig Dis Sci 2015 Jun;60(6):1825-31 21 Citations |
| 2 | Truncating mutation in the nitric oxide synthase 1 gene is associated with infantile achalasia. (Shteyer E, Edvardson S, Wynia-Smith SL, Pierri CL, Zangen T, Hashavya S, Begin M, Yaacov B, Cinamon Y, Koplewitz BZ, Vromen A, Elpeleg O, Smith BC) Gastroenterology 2015 Mar;148(3):533-536.e4 37 Citations |
| 1 | Response to: laboratory assessment may be dependent on the time of liver biopsy. (Goh GB, Pagadala M, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough A, Dasarathy S) Liver Int 2015 Jan;35(1):287-8 |
| 1 | Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. (Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough AJ, Dasarathy S) Liver Int 2015 Mar;35(3):979-85 108 Citations |
| 1 | Management of non-alcoholic fatty liver disease. (Sourianarayanane A, Pagadala MR, Kirwan JP) Minerva Gastroenterol Dietol 2013 Mar;59(1):69-87 11 Citations |
| 1 | Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. (Singh GK, Vitola BE, Holland MR, Sekarski T, Patterson BW, Magkos F, Klein S) J Pediatr 2013 Jun;162(6):1160-8, 1168.e1 65 Citations |
| 1 | Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. (Sourianarayanane A, Garg G, Smith TH, Butt MI, McCullough AJ, Shen B) J Crohns Colitis 2013 Sep;7(8):e279-85 121 Citations |
| 1 | Predictors of nonalcoholic steatohepatitis in obese children. (Lerret SM, Garcia-Rodriguez L, Skelton J, Biank V, Kilway D, Telega G) Gastroenterol Nurs 2011;34(6):434-7 9 Citations |
| 1 | The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis. (Tevar AD, Clarke CN, Schuster R, Wang J, Edwards MJ, Lentsch AB) J Surg Res 2011 Jul;169(1):e7-14 13 Citations |
| 1 | Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology. (Gawrieh S, Knoedler DM, Saeian K, Wallace JR, Komorowski RA) Ann Diagn Pathol 2011 Feb;15(1):19-24 88 Citations |
